OTCMKTS:MCUJF Medicure (MCUJF) Stock Price, News & Analysis $0.53 0.00 (0.00%) As of 01/29/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest About Medicure Stock (OTCMKTS:MCUJF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medicure alerts:Sign Up Key Stats Today's Range$0.53▼$0.5350-Day Range$0.53▼$0.7052-Week Range$0.53▼$1.03VolumeN/AAverage Volume977 shsMarket Capitalization$5.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Read More… Receive MCUJF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Email Address MCUJF Stock News HeadlinesMedicure Sees Revenue Growth in Q3 2024November 25, 2024 | tipranks.comMedicure, Inc.: Medicure Announces Positive Settlement of Product Development and Supply ContractsOctober 25, 2024 | finanznachrichten.deIs this the pin that pops the bubble? CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia… In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers. Go here now before it’s too late to find out why Nvidia shares are slumping so hard.January 30, 2025 | Porter & Company (Ad)Medicure Second Quarter 2024 Earnings: CA$0.12 loss per share (vs CA$0.024 profit in 2Q 2023)August 18, 2024 | finance.yahoo.comMedicure, Inc.: Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual PropertyAugust 15, 2024 | finanznachrichten.deMedicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election ResultsMay 28, 2024 | finance.yahoo.comMedicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 DiabetesDecember 5, 2023 | finance.yahoo.comMedicure approved to enrol patients in paediatric disease trialNovember 24, 2023 | msn.comSee More Headlines MCUJF Stock Analysis - Frequently Asked Questions How have MCUJF shares performed this year? Medicure's stock was trading at $0.62 at the beginning of the year. Since then, MCUJF stock has decreased by 14.2% and is now trading at $0.5320. View the best growth stocks for 2025 here. How were Medicure's earnings last quarter? Medicure Inc. (OTCMKTS:MCUJF) announced its earnings results on Monday, November, 25th. The company reported $0.05 earnings per share for the quarter. Medicure had a negative trailing twelve-month return on equity of 10.12% and a negative net margin of 9.62%. How do I buy shares of Medicure? Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/25/2024Today1/30/2025Next Earnings (Estimated)4/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:MCUJF CUSIPN/A CIK1133519 Webwww.medicure.com Phone(204) 487-7412Fax204-488-9823EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-680,000.00 Net Margins-9.62% Pretax Margin-9.24% Return on Equity-10.12% Return on Assets-7.13% Debt Debt-to-Equity Ratio0.03 Current Ratio2.03 Quick Ratio1.64 Sales & Book Value Annual Sales$16.07 million Price / Sales0.35 Cash Flow$0.09 per share Price / Cash Flow6.00 Book Value$1.41 per share Price / Book0.38Miscellaneous Outstanding Shares10,440,000Free Float9,090,000Market Cap$5.55 million OptionableNot Optionable Beta1.00 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:MCUJF) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.